Completed NA INTERVENTIONAL 2-arm NCT03035071

Morbidity in Open Versus Minimally Invasive Esophagectomy (MIOMIE)

Morbidity In Open Versus Minimally Invasive Hybrid Esophagectomy

Sponsor: Austrian Society Of Surgical Oncology

Interventions minimally invasive esophagectomy open esophagectomy

Updated 5 times since 2017 Last updated: Jan 26, 2017 Started: May 1, 2010 Primary completion: Nov 19, 2014 Completion: Apr 18, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Esophageal Cancer, this trial is completed. The trial is conducted by Austrian Society Of Surgical Oncology and has accumulated 5 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Austrian Society Of Surgical Oncology

Data source: Austrian Society Of Surgical Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.